Article
[Genetic polymorphisms and cancer risk].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Jun 2004
Hamajima Nobuyuki
Abstract excerpt
While hereditary disease genes have a high lifelong cumulative incidence rate (penetrance), the penetrance for polymorphism genotypes is not high. Polymorphisms relating to cancer incidence are classified into 1. carcinogen metabolizing enzymes (CYPs, GSTs, NQO1, etc.), 2. DNA repair enzymes (OGG1, XRCC1, XPD, etc.), 3. DNA synthesis and methylation (MTHFR, MS, etc.), 4. cytokines and inflammation-related enzymes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
